NASDAQ:OREX - Orexigen Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
Previous Close$0.2229
Today's RangeN/A
52-Week Range$0.17 - $3.81
VolumeN/A
Average Volume1.16 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Orexigen Therapeutics (NASDAQ:OREX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Orexigen Therapeutics in the last 12 months. Their average twelve-month price target is $0.02The high price target for OREX is $0.02 and the low price target for OREX is $0.02. There are currently 1 sell rating for the stock, resulting in a consensus rating of "Sell."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: SellSellSellSell
Consensus Rating Score: 1.001.001.001.00
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $0.02$0.02$0.02$0.02
Price Target Upside: N/A91.03% downside91.03% downside91.03% downside

Orexigen Therapeutics (NASDAQ:OREX) Consensus Price Target History

Price Target History for Orexigen Therapeutics (NASDAQ:OREX)

Orexigen Therapeutics (NASDAQ:OREX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/15/2018S&P Equity ResearchLower Price Target$0.03 ➝ $0.02LowView Rating Details
3/13/2018Wells Fargo & CoDowngradeUnderperformHighView Rating Details
(Data available from 2/23/2017 forward)
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel